These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy. Viswanathan M; Anchin JM; Droupadi PR; Mandal C; Linthicum DS; Subramaniam S Biophys J; 1995 Sep; 69(3):741-53. PubMed ID: 8519975 [TBL] [Abstract][Full Text] [Related]
9. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins. Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728 [TBL] [Abstract][Full Text] [Related]
10. Ligand-induced domain movement in an antibody Fab: molecular dynamics studies confirm the unique domain movement observed experimentally for Fab NC6.8 upon complexation and reveal its segmental flexibility. Sotriffer CA; Liedl KR; Linthicum DS; Rode BM; Varga JM J Mol Biol; 1998 May; 278(2):301-6. PubMed ID: 9571052 [TBL] [Abstract][Full Text] [Related]
11. Cocrystal structures of NC6.8 Fab identify key interactions for high potency sweetener recognition: implications for the design of synthetic sweeteners. Gokulan K; Khare S; Ronning DR; Linthicum SD; Sacchettini JC; Rupp B Biochemistry; 2005 Jul; 44(29):9889-98. PubMed ID: 16026161 [TBL] [Abstract][Full Text] [Related]
12. Modeling the structure of the combining site of an antisweet taste ligand monoclonal antibody NC10.14. Viswanathan M; Subramaniam S; Pledger DW; Tetin SY; Linthicum DS Biopolymers; 1996 Sep; 39(3):395-406. PubMed ID: 8756519 [TBL] [Abstract][Full Text] [Related]
13. Variable region sequence and characterization of monoclonal antibodies to a N,N',N"-trisubstituted guanidine high potency sweetener. Anchin JM; Linthicum DS Mol Immunol; 1993 Nov; 30(16):1463-71. PubMed ID: 8232332 [TBL] [Abstract][Full Text] [Related]
14. Absorption spectroscopy of the complexation between superpotent guanidinium sweeteners and specific monoclonal antibodies. Droupadi PR; Linthicum DS Int J Biochem Cell Biol; 1995 Apr; 27(4):351-7. PubMed ID: 7788557 [TBL] [Abstract][Full Text] [Related]
15. Computer-aided molecular modeling of the binding site architecture for eight monoclonal antibodies that bind a high potency guanidinium sweetener. Anchin JM; Mandal C; Culberson C; Subramaniam S; Linthicum DS J Mol Graph; 1994 Dec; 12(4):257-66, 289-90. PubMed ID: 7696216 [TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3. Paula S; Monson N; Ball WJ Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis. Kortt AA; Nice E; Gruen LC Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809 [TBL] [Abstract][Full Text] [Related]
18. Analysis of correlated motion in antibody combining sites from molecular dynamics simulations. Viswanathan M; Linthicum DS; Subramaniam S Methods; 2000 Mar; 20(3):362-71. PubMed ID: 10694457 [TBL] [Abstract][Full Text] [Related]
19. Identification of important residues in metal-chelate recognition by monoclonal antibodies. Delehanty JB; Jones RM; Bishop TC; Blake DA Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody. Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]